Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$46.1M Sell
949,381
-17,402
-2% -$788K 0.79% 40
2017
Q1
$42.9M Buy
966,783
+405,465
+72% +$17.5M 0.77% 44
2016
Q4
$21.6M Sell
561,318
-37,873
-6% -$1.5M 0.42% 67
2016
Q3
$25.3M Buy
599,191
+485,019
+425% +$20.8M 0.48% 64
2016
Q2
$4.49M Buy
114,172
+1,597
+1% +$63.6K 0.09% 122
2016
Q1
$4.71M Sell
112,575
-840
-0.7% -$33.3K 0.09% 116
2015
Q4
$5.09M Buy
113,415
+24,997
+28% +$1.1M 0.1% 110
2015
Q3
$3.56M Sell
88,418
-3,725
-4% -$176K 0.07% 136
2015
Q2
$4.52M Buy
92,143
+1,113
+1% +$53.4K 0.08% 138
2015
Q1
$4.22M Sell
91,030
-1,515
-2% -$69.6K 0.08% 142
2014
Q4
$4.17M Sell
92,545
-3,723
-4% -$162K 0.08% 139
2014
Q3
$4M Sell
96,268
-1,529
-2% -$64.7K 0.08% 145
2014
Q2
$4M Buy
97,797
+12,816
+15% +$503K 0.07% 148
2014
Q1
$3.27M Buy
84,981
+54,329
+177% +$2.09M 0.06% 163
2013
Q4
$1.18M Sell
30,652
-516
-2% -$19K 0.02% 236
2013
Q3
$1.03M Sell
31,168
-2,921
-9% -$102K 0.02% 245
2013
Q2
$1.19M Buy
+34,089
New +$1.25M 0.03% 201

Other funds holding ABT

Geneva Advisors's ABT Position: Q2 2017 in Review

Geneva Advisors reduced its Abbott (ABT) stake by 1.8% in Q2 2017, selling an estimated $788K and leaving 949,381 shares worth $46.1M. The position accounts for 0.79% of the portfolio, ranked #40.

Geneva Advisors first reported a position in ABT in Q2 2013 and has held it in 17 quarters since. 1,576 funds tracked by Wall St. Rank hold ABT as of Q2 2017.

  • Geneva Advisors held 949,381 shares of Abbott worth $46.1M as of Q2 2017.
  • Geneva Advisors sold 17,402 Abbott shares in Q2 2017, an estimated $788K.
  • Abbott made up 0.79% of Geneva Advisors's portfolio in Q2 2017, its #40 holding.
  • Geneva Advisors first reported a position in Abbott in Q2 2013 and has held it in 17 quarters since.
  • 1,576 funds tracked by Wall St. Rank held Abbott as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.